168 related articles for article (PubMed ID: 6096607)
1. [Effects of 3 different angiotensin converting enzyme inhibitors, MK 421, SQ 14225 and SA 446 on renal function and blood pressure in patients with essential hypertension].
Tajima J; Abe K; Yasujima M; Tanno M; Yoshinaga K
Nihon Jinzo Gakkai Shi; 1984 Jun; 26(6):779-89. PubMed ID: 6096607
[No Abstract] [Full Text] [Related]
2. A comparison of inhibition of angiotensin I conversion by three converting enzyme inhibitors in rats.
Takata Y; Di Nicolantonio R; Hutchinson JS
Clin Exp Pharmacol Physiol Suppl; 1982; 7():129-34. PubMed ID: 6183035
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the acute effects of three structurally different converting enzyme inhibitors (captopril, SA-446 and MK-421) on blood pressure, the renin-angiotensin system and the kallikrein-kinin system.
Kondo K; Kida O; Kodama K; Higa T; Someya N; Morotomi Y; Tanaka K
Nihon Jinzo Gakkai Shi; 1985 Mar; 27(3):337-42. PubMed ID: 2991635
[No Abstract] [Full Text] [Related]
4. A comparison of the activity of the angiotensin converting enzyme inhibitors SQ 14 225, SA 446, and MK 421.
Takata Y; Di Nicolantonio R; Mendelsohn FA; Hutchinson JS; Doyle AE
Clin Exp Pharmacol Physiol; 1983; 10(2):131-45. PubMed ID: 6307563
[No Abstract] [Full Text] [Related]
5. In vivo comparison of three orally active inhibitors of angiotensin-converting enzyme.
DiNicolantonio R; Dinicolantonio R; Hutchinson JS; Mendelsohn FA; Doyle AE
Am J Cardiol; 1982 Apr; 49(6):1502-4. PubMed ID: 6280478
[TBL] [Abstract][Full Text] [Related]
6. Effects of converting enzyme inhibitors on renin-angiotensin system in normal rats.
Komori T; Takada T; Funae Y; Yamamoto K
Osaka City Med J; 1984 Jun; 30(1):17-30. PubMed ID: 6096787
[No Abstract] [Full Text] [Related]
7. [Renal adaptation to a restriction of sodium intake in the rat: effects of inhibition of the renin-angiotensin system].
Jover B; Dupont M; Casellas D; Mimran A
Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1234-7. PubMed ID: 6098235
[TBL] [Abstract][Full Text] [Related]
8. Effects of angiotensin I converting enzyme inhibitors on the renal excretory function, hemodynamics and renin release in isolated perfused rat kidney.
Ogihara T; Yoshizawa M; Yasui T; Nakane H; Nakane Y; Saruta T
Jpn Heart J; 1983 Nov; 24(6):975-83. PubMed ID: 6323782
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of converting enzyme inhibition: studies in experimental animals.
Dinicolantonio R; Mendelsohn FA; Takata Y; Hutchinson JS; Doyle AE
Neth J Med; 1984; 27(4):153-60. PubMed ID: 6330589
[No Abstract] [Full Text] [Related]
10. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
McCaa RE; Gillespie JB
Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
[TBL] [Abstract][Full Text] [Related]
11. Responses of the kallikrein-kinin system to angiotensin converting enzyme inhibitors in the rat.
Yasujima M; Abe K; Tanno M; Omata K; Yoshinaga K
Jpn Circ J; 1984 Feb; 48(2):173-9. PubMed ID: 6321815
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin converting enzyme inhibition in tissues from spontaneously hypertensive rats after treatment with captopril or MK-421.
Cohen ML; Kurz KD
J Pharmacol Exp Ther; 1982 Jan; 220(1):63-9. PubMed ID: 6273529
[No Abstract] [Full Text] [Related]
13. Complex competitive and non-competitive inhibition of rat lung angiotensin-converting enzyme by inhibitors containing thiol groups: captopril and SA 446.
Mendelsohn FA; Csicsmann J; Hutchinson JS
Clin Sci (Lond); 1981 Dec; 61 Suppl 7():277s-280s. PubMed ID: 6172236
[TBL] [Abstract][Full Text] [Related]
14. [Effect of enalapril maleate (MK-421) on blood pressure, renin-angiotensin system and kallikrein-kinin system in patients with essential hypertension].
Shionoiri H; Akema N; Tanaka K; Miyazaki N; Gotoh E; Kaneko Y
Nihon Jinzo Gakkai Shi; 1984 Jun; 26(6):759-65. PubMed ID: 6096606
[No Abstract] [Full Text] [Related]
15. Renal kallikrein-kinin system and the depressor effect of angiotensin converting enzyme inhibitors MK 421, SA 446, and captopril in rats.
Yasujima M; Abe K; Kasai Y; Tanno M; Tajima J; Seino M; Chiba S; Sato K; Goto T; Omata K
Clin Exp Hypertens A; 1984; 6(6):1207-25. PubMed ID: 6086184
[TBL] [Abstract][Full Text] [Related]
16. SA446, a new orally active converting enzyme inhibitor: antihypertensive action and comparison with captopril in stroke-prone spontaneously hypersensitive rats.
Unger T; Yukimura T; Marin-Grez M; Lang RE; Rascher W; Ganten D
Eur J Pharmacol; 1982 Mar; 78(4):411-20. PubMed ID: 6281036
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the effects of two angiotensin converting enzyme inhibitors, SQ 14 225 and MK 422 in Na-restricted sheep.
Nelson MA; Stewart KW; Coghlan JP; Denton DA; Fei DT; Scoggins BA
Clin Exp Pharmacol Physiol Suppl; 1982; 7():87-91. PubMed ID: 6183038
[TBL] [Abstract][Full Text] [Related]
18. Effects of three different kininase II inhibitors on blood pressure and renal vasoactive substances in essential hypertensives.
Abe K; Tajima J; Omata K; Tanno M; Tsunoda K; Kudo K; Onoda Y; Kohzuki M; Sasaki S; Takeuchi K
Adv Exp Med Biol; 1986; 198 Pt B():269-77. PubMed ID: 3028076
[No Abstract] [Full Text] [Related]
19. [Effects of angiotensin converting enzyme inhibitor SQ 14,225 on the blood pressure, renin-angiotensin-aldosterone system and renal function in patients with malignant hypertension (author's transl)].
Shionoiri H; Uneda S; Tochikubo O; Ohonishi T; Harada J; Sesoko S; Goto E; Fujishima S; Kaneko Y
Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):13-22. PubMed ID: 6247528
[No Abstract] [Full Text] [Related]
20. [Angiotensin converting enzyme inhibitors--a new group of hypotensive drugs].
Lazowski J
Wiad Lek; 1984 May; 37(10):792-6. PubMed ID: 6095537
[No Abstract] [Full Text] [Related]
[Next] [New Search]
